Clicky

ChromaDex Corporation(CDXC) News

Date Title
Sep 26 ChromaDex to Participate in a Fireside Chat at the Lytham Partners Fall 2024 Investor Conference
Sep 26 Is ChromaDex (CDXC) Stock Outpacing Its Medical Peers This Year?
Sep 20 ChromaDex Appoints Ozan Pamir as Chief Financial Officer
Sep 17 3 US Growth Companies With High Insider Ownership
Sep 15 Insiders own 31% of ChromaDex Corporation (NASDAQ:CDXC) shares but retail investors control 42% of the company
Jul 24 ChromaDex to Report Second Quarter 2024 Financial Results on Wednesday, August 7, 2024
Jul 23 ChromaDex Launches Niagen+ NAD+ Test Kit Available Exclusively to Health Care Practitioners (HCPs)
Jul 16 ChromaDex Announces Pharmaceutical-Grade Intravenous and Injectable Niagen® Will Debut at Leading Wellness Clinics in August
Jun 24 Milestone Phase II Clinical Study Demonstrates Niagen®, Patented Nicotinamide Riboside (NR), Improves Functional Mobility for Individuals with Peripheral Artery Disease (PAD)
Jun 10 ChromaDex (CDXC) Up as Ataxia Candidate Gets Orphan Drug Tag
Jun 7 ChromaDex Receives Exclusive U.S. FDA Orphan Drug Designation (ODD) and Rare Pediatric (RPD) Disease Designation for Nicotinamide Riboside Chloride (NRC) for the Treatment of Ataxia Telangiectasia (AT)
May 10 ChromaDex Corp (CDXC) Q1 2024 Earnings: Aligns with EPS Projections, Misses Revenue Estimates
May 9 ChromaDex Corporation (NASDAQ:CDXC) Q1 2024 Earnings Call Transcript
May 9 Q1 2024 Chromadex Corp Earnings Call
May 9 ChromaDex Corp (CDXC) Q1 2024 Earnings Call Transcript Highlights: Navigating Challenges and ...
May 8 ChromaDex Corporation Reports First Quarter 2024 Financial Results
May 6 An Intrinsic Calculation For ChromaDex Corporation (NASDAQ:CDXC) Suggests It's 43% Undervalued
Apr 30 ChromaDex’s NIAGEN® (Patented Nicotinamide Riboside, NR), the Most Efficient and High-Quality NAD+ Precursor, Featured in New Solgar® Cellular Nutrition Cellular Energy Supplement
Apr 25 ChromaDex Announces Nationwide Launch of Tru Niagen® at The Vitamin Shoppe®
Apr 24 ChromaDex to Report First Quarter 2024 Financial Results on Wednesday, May 8, 2024